Business Description
Impedimed Ltd
SIC : 3840
ISIN : AU000000IPD8
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 28.99 | |||||
Equity-to-Asset | 0.87 | |||||
Debt-to-Equity | 0.03 | |||||
Debt-to-EBITDA | -0.06 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 6.16 | |||||
Beneish M-Score | -2.5 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -15.7 | |||||
3-Year EBITDA Growth Rate | 35.5 | |||||
3-Year EPS without NRI Growth Rate | 32.6 | |||||
3-Year FCF Growth Rate | 28.8 | |||||
3-Year Book Growth Rate | 3.6 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 22.52 | |||||
9-Day RSI | 33.18 | |||||
14-Day RSI | 37.78 | |||||
6-1 Month Momentum % | -33.85 | |||||
12-1 Month Momentum % | -42.67 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 7 | |||||
Quick Ratio | 6.85 | |||||
Cash Ratio | 6.23 | |||||
Days Inventory | 256.68 | |||||
Days Sales Outstanding | 92.27 | |||||
Days Payable | 618.12 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -26.3 | |||||
Shareholder Yield % | -17.76 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 86.78 | |||||
Operating Margin % | -229.41 | |||||
Net Margin % | -187.8 | |||||
FCF Margin % | -170.82 | |||||
ROE % | -38.19 | |||||
ROA % | -33.19 | |||||
ROIC % | -118.3 | |||||
ROC (Joel Greenblatt) % | -1117.49 | |||||
ROCE % | -45.12 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 19.5 | |||||
PB Ratio | 3.12 | |||||
Price-to-Tangible-Book | 3.9 | |||||
EV-to-EBIT | -5.23 | |||||
EV-to-Forward-EBIT | -7.22 | |||||
EV-to-EBITDA | -5.85 | |||||
EV-to-Forward-EBITDA | -8.39 | |||||
EV-to-Revenue | 12.01 | |||||
EV-to-Forward-Revenue | 5.86 | |||||
EV-to-FCF | -7.26 | |||||
Price-to-Median-PS-Value | 0.65 | |||||
Price-to-Net-Current-Asset-Value | 3.9 | |||||
Price-to-Net-Cash | 7.8 | |||||
Earnings Yield (Greenblatt) % | -19.12 | |||||
FCF Yield % | -11.05 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Impedimed Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil A$) | 10.343 | ||
EPS (TTM) (A$) | -0.01 | ||
Beta | 2.18 | ||
Volatility % | 68.85 | ||
14-Day RSI | 37.78 | ||
14-Day ATR (A$) | 0.00471 | ||
20-Day SMA (A$) | 0.08175 | ||
12-1 Month Momentum % | -42.67 | ||
52-Week Range (A$) | 0.076 - 0.24 | ||
Shares Outstanding (Mil) | 2,023.09 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Impedimed Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Impedimed Ltd Stock Events
Event | Date | Price(A$) | ||
---|---|---|---|---|
No Event Data |
Impedimed Ltd Frequently Asked Questions
What is Impedimed Ltd(ASX:IPD)'s stock price today?
When is next earnings date of Impedimed Ltd(ASX:IPD)?
Does Impedimed Ltd(ASX:IPD) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |